Harrisson S et al. Six month interim results of MSDC-0602K in a large phase 2b NASH study demonstrate significant improvement in liver enzymes and glycemic control (NCT02784444). (Abstract PS-111)
Radboud start fase I/II-studie naar COVID-19-vaccin
mrt 2021 | Vaccinatie, Virale infecties